Immunotherapy Part 3: Common Controversies and Remaining Questions

This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing.

Moderator:
Karin K. Shih, MD
Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell

Speakers:
Erin Zacholski, PharmD, BCOP
Assistant Professor - VCU School of Pharmacy
Clinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer Center

Sarah Hayward, PharmD, BCOP
Clinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

Keywords: immunotherapy, toxicities, immunotherapy toxicities, immune-related adverse events, high-grade toxicities

Target Audience

SGO Members 

You may also be interested in

Immunotherapy Part 1: Basics of Immune-Related Adverse Events
This episode is part 1 of the Immunotherapy podcast series, which reviews immune-checkpoint inhibitors encountered in the gynecologic oncology setting, common immunotherapy toxicities and patient counseling on them, as well as the basic treatment course for patients with high-grade toxicities.
Immunotherapy Part 2: Common Controversies
This episode is part 2 of the Immunotherapy Series.
Course summary
Course opens: 
03/12/2024
Course expires: 
03/12/2029
Cost:
$0.00
Rating: 
0

Price

Cost:
$0.00
Please login or register to take this course.